Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma [5]

Bone Marrow Transplantation

Volumn 36, Issue 8, 2005, Pages 739-740

  Tong, J ^a   Laport, G ^a   Lowsky, R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; GEMFIBROZIL; GLIBENCLAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN KAPPA CHAIN; LEVOTHYROXINE; M PROTEIN; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; PAMIDRONIC ACID; SIMVASTATIN; TACROLIMUS; THALIDOMIDE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APHERESIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE PAIN; CANCER STAGING; CASE REPORT; COMORBIDITY; CREATINE KINASE BLOOD LEVEL; CRYOPRESERVATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; ELECTROMYOGRAPHY; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; HYDRATION; HYPERTENSION; HYPOGONADISM; LETTER; MALE; MONONUCLEAR CELL; MULTIPLE MYELOMA; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYALGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHABDOMYOLYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; WEIGHT BEARING; WHOLE BODY RADIATION;

ANTILIPEMIC AGENTS; CYCLOSPORINE; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RHABDOMYOLYSIS; SIMVASTATIN; STEM CELL TRANSPLANTATION;

EID: 27244441827     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705128     Document Type: Letter

References (9)

1. Alyea EP, Kim HT, Ho V et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005; 105: 1810-1814.
2. Yancik R, Ganz PA, Varricchio CG, Conley B. Perspectives in comorbidity and cancer in older patients: Approaches to expand the knowledge base. J Clin Oncol 2001; 19: 1147-1154.
3. Blower P, de Wit R, Goodin S, Aapro M. Drug-drug interactions in oncology: Why are they important and can they be minimized? Crit Rev Oncol Hematol 2005; 55: 117-142.
4. Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003; 48: 133-143.
5. Jamal SM, Eisenberg MJ, Christopoulos S. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors. Am Heart J 2004; 147: 956-965.
6. Gumprecht J, Zychma M, Grzesczczak W et al. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient. Med Sci Monit 2003; 9: 89-91.
7. Tobert JA. Efficacy and long-term adverse effect pattern of lovastatin. Am J Cordiol 1988; 62: 28J-34J.
8. Keogh A, Macdonald P, Kaan A et al. Efficacy and safety of pravastatin and simvastatin after cardiac transplantation. J Heart Lung Transplant 2000; 19: 529-537.
9. Bellosta S, Paoletti R, Corsini A. Safety of statins: Focus on clinical pharmacokinetics and drug interactions. Circulation 2004; 109 (23 Suppl. 1): III50-III57.